enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   Combination of sulfonylureas plus metformin – known by generic names of the two drugs; No generics are available for dipeptidyl peptidase-4 inhibitors (Onglyza), the glifozins, the incretins and various combinations. Sitagliptin patent expired in July 2022, leading to launch of generic sitagliptin [57] brands . This lowered the cost of ...

3. FDA approves generic in same class as Ozempic for diabetes ...

   www.aol.com/news/fda-approves-generic-same-class...

   FDA's approval of a generic GLP-1 might eventually ease the price, demand for weight loss drugs.

4. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

5. Does Medicare cover Basaglar? - AOL

   www.aol.com/does-medicare-cover-basaglar...

   In 2025, a person will pay no more than $4.90 for generic drugs or $12.15 for brand-name drugs through Extra Help. Generic drugs or other lower cost drugs: As Basaglar is a brand-name drug, it may ...

6. Dulaglutide - Wikipedia

   en.wikipedia.org/wiki/Dulaglutide

   Dulaglutide, sold under the brand name Trulicity among others, [8] is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. [9] [10] It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

7. Teva launches generic version of Novo Nordisk's diabetes drug ...

   www.aol.com/news/teva-launches-generic-version...

   Victoza, chemically known as liraglutide, is a once-daily injection approved for use in adults and children aged 10 or older with type 2 diabetes. The drug brought in annual sales of $1.66 billion ...